糖尿病患者服用胰岛素增敏剂的同样发生阿尔采默病的风险也低。
And diabetics who take pills that help their bodies use insulin better have a lower risk of Alzheimer's.
目的：探讨胰岛素增敏剂罗格列酮对糖尿病患者肾脏的保护作用。
Objective:To explore the protecting function of insulin increasing sensitivity agent rosiglitazone on kidney of diabetic patients.
多囊卵巢综合症最常用治疗之一是胰岛素增敏剂，它有时可以恢复生殖能力。
One of the most common treatments for PCOS is insulin sensitizers, which can sometimes restore fertility.
结论R2很可能是胰岛素增敏剂吡格列酮改善肝脏胰岛素敏感性的重要作用机制之一。
Conclusions The increased expression of R2 mRNA may play a important role in pioglitazone-induced insulin sensitivity amelioration.
二甲双胍是一种胰岛素增敏剂，多年来被广泛应用于对2型糖尿病患者的降血糖治疗。
The biguanide metformin is one of the mostly used drugs for treatment of type 2 diabetes.
随着胰岛素、促胰岛素分泌剂、胰岛素增敏剂等药物的不断开发与应用，糖尿病的治疗有了更多的手段。
With the development and application of anti-diabetic drugs, such as insulin, insulin secreting drugs, insulin sensitizing agents, we have more choices for the treatment of diabetes mellitus.
目的观察胰岛素增敏剂二甲双胍治疗2型糖尿病，降低血浆胰岛素水平、改善胰岛素敏感性后对血压的影响。
Objective To investigate the effects of insulin increasing sensitivity agent(Metformin) on blood pressure in type 2 diabetic patients.
《国际糖尿病》：二甲双胍通常被看作是胰岛素增敏剂。在改善胰岛素抵抗方面，二甲双胍和吡格列酮的区别有哪些？
International Diabetes: metformin is often viewed as an insulin sensitizer. What is the difference between metformin and pioglitazone with regard to improving insulin resistance?
不过有其他的研究发现对那些同时患有炎症和糖尿病的人，胰岛素增敏剂似乎能降低炎症，而抗炎症疗法也能提高胰岛素敏感性。
Other studies have shown that in patients who have inflammation and diabetes, insulin-sensitizing drugs seem to reduce inflammation while anti-inflammatory therapies improve sensitivity to insulin.
二甲双胍和吡格列酮都是胰岛素增敏剂，因此这两类药物不会导致低血糖，而GLP-1类似物或DPP-IV抑制剂导致低血糖的概率也很低。
The metformin and pioglitazone are insulin sensitizers so they never lower you blood glucose below normal and the GLP-1 analogues or DPP-IV inhibitors also never lower your blood glucose below normal.
二甲双胍和吡格列酮都是胰岛素增敏剂，因此这两类药物不会导致低血糖，而GLP-1类似物或DPP-IV抑制剂导致低血糖的概率也很低。
The metformin and pioglitazone are insulin sensitizers so they never lower you blood glucose below normal and the GLP-1 analogues or DPP-IV inhibitors also never lower your blood glucose below normal.
应用推荐